Pacira | PCRX - Créances Commerciales





Créances Commerciales Changement Date
Assertio Holdings USD 39.91M 2.7M 2024-06
Astellas Pharma JPY 810.23B 75.43B 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Cara Therapeutics USD 2.24M 2.26M 2025-03
Coherus Biosciences USD 18.42M 232.08M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
J&J USD 17.61B 235M 2025-09
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Novo Nordisk DKK 95.05B 2.4B 2025-12
Omeros USD 8.08M 440K 2024-06
Pacira USD 124.07M 8.8M 2025-12
Perrigo USD 612.8M 31.6M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Supernus Pharmaceuticals USD 187.8M 16.55M 2025-12
Teva Pharmaceutical Industries USD 3.71B 101M 2025-12
Xeris Pharmaceuticals USD 51.05M 2.7M 2025-12
Xoma USD 14.78M 4.96M 2024-06
Zoetis USD 1.59B 49M 2025-12